Global Antibiotic R&D Partnership (GARDP)

  1. Αρχική Σελίδα
  2. /
  3. Χωρίς κατηγορία
  4. /
  5. Global Antibiotic R&D Partnership (GARDP)

Posted in : Χωρίς κατηγορία on

REVIVE WEBINARS

All webinars are recorded and can be viewed on revive.gardp.org/webinars

 

Title:

Test tube to patient: PK/PD of fixed dose beta-lactam/beta-lactamase inhibitor combinations

 

Speaker:

Vincent H. Tam, Professor, University of Houston College of Pharmacy, USA

 

Moderator:

Shampa Das, Senior Lecturer, Centre of Excellence in Infectious Diseases Research, University of Liverpool, UK

 

 

Date and time:

9 June, 17:00-18:30 CEST. Find your time zone here.

                                              Register here for this live webinar:

https://attendee.gotowebinar.com/register/374164212748744460?source=societies

Title:

Bringing new treatments for drug-resistant infections to all who need them

 

Speakers:

Seamus O’ Brien, R&D Director, GARDP, Switzerland

François Franceschi, Asset Evaluation and Development Project Leader, GARDP, Switzerland

Sally Ellis, Neonatal Sepsis Project Leader, GARDP, Switzerland

 

Moderator:

Laura Piddock, Director of Scientific Affairs, GARDP, Switzerland

 

 

Date and time:

16 June, 17:00-18:30 CEST. Find your time zone here.

                                              Register here for this live webinar:

https://attendee.gotowebinar.com/register/1623975782681890832?source=societies

Title:

Putting children first in the fight against antibiotic resistance

 

Speakers:

Manica Balasegaram, Executive Director, GARDP, Switzerland

Hanan Balkhy, Assistant Director-General for Antimicrobial resistance, WHO, Switzerland

Stefan Peterson, Chief of Health, UNICEF, Switzerland

 

Moderator:

Claire Doole

 

 

Date and time:

25 June, 14:00-15:00 CEST. Find your time zone here.

                                             Register here for this live webinar:

https://attendee.gotowebinar.com/register/1830315632306301195?source=societies

Title:

Clinical development of antimicrobials – Phase 1 development challenges

 

Speaker:

Markus Zeitlinger, Department of Clinical Pharmacology, Medical University of Vienna, Austria

 

Moderator:

Markus Heep,  Medical Lead Zoliflodacin programme, GARDP, Switzerland

 

 

Date and time:

30 June, 17:00-18:30 CEST. Find your time zone here.

                                               Register here for this live webinar:

https://attendee.gotowebinar.com/register/1537073681113177101?source=societies

Title:

The challenges and opportunities for antimicrobial R&D in low- and middle-income countries – India case study

 

Speakers:

Anand Anandkumar, Co-founder and CEO Bugworks Research Inc, India,

Kamini Walia, Program Officer, Indian Council of Medical Research – AMR Initiative, India

 

Moderator:

François Franchesci, GARDP, Switzerland

 

 

Date and time:

9 July, 09:00-10:30 CEST. Find your time zone here.

                                              Register here for this live webinar:

https://attendee.gotowebinar.com/register/6308228466861933057?source=societies

 

ANTIMICROBIAL VIEWPOINTS

In our Antimicrobial Viewpoints series, we invite experts of different aspects of antimicrobial resistance (AMR) to share their knowledge and opinions about the current status and the future challenges of this field. Our latest articles can be found below:

 

· Getting the most out of antimicrobial surveillance by Mariana Castanheira

· COVID-19 and antimicrobial resistance: Are there any unknowns that will become             known? by Stephan Harbarth

· COVID-19 and its impact on antimicrobial stewardship by Andrew Seaton

· The critical need for alternative approaches to address antibiotic treatment failure by Bob     Hancock (University of British Columbia)